NASDAQ · Biotechnology
Recursion Pharmaceuticals Inc (RXRX)
$2.45
-9.93%
34
In band
Moving averages
SMA 200$3.49-29.80%
Company profile
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that decodes biology by integrating technological innovations in biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company is headquartered in Salt Lake City, Utah.
SectorHealthcare
IndustryBiotechnology
Market cap$2.24B
P/E ratioNone
EPS$-0.86
Beta1.15
Dividend yield0.00%
52-week high$5.24
52-week low$2.77
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 32
VRTX
Vertex Pharmaceuticals Inc
RSI 43
CRSP
CRISPR Therapeutics AG
RSI 27
IOVA
Iovance Biotherapeutics Inc
RSI 31
AUPH
Aurinia Pharmaceuticals Inc
RSI 32
MRVI
Maravai LifeSciences Holdings Inc - Class A
RSI 48
ATAI
ATAI Life Sciences N.V.
RSI 62
SRPT
Sarepta Therapeutics Inc
RSI 29
NVAX
Novavax Inc
RSI 33
NTLA
Intellia Therapeutics Inc
RSI 37
RSI alerts for RXRX
An email when RXRX closes below RSI 30 or above 70. Nothing else.
Data last updated 13 November 2026 at 1:44 AM EST